Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

332 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Tacrolimus does not abrogate the increased risk of acute graft-versus-host disease after unrelated-donor marrow transplantation with allelic mismatching at HLA-DRB1 and HLA-DQB1.
Przepiorka D, Saliba R, Cleary K, Fischer H, Tonai R, Fritsche H, Khouri IF, Folloder J, Ueno NT, Mehra R, Ippoliti C, Giralt S, Gajewski J, Donato M, Claxton D, Braunschweig I, van Besien K, Anderlini P, Andersson BS, Champlin R. Przepiorka D, et al. Among authors: van besien k. Biol Blood Marrow Transplant. 2000;6(2A):190-7. doi: 10.1016/s1083-8791(00)70042-5. Biol Blood Marrow Transplant. 2000. PMID: 10816027 Free article.
Allogeneic transplantation for advanced leukemia: improved short-term outcome with blood stem cell grafts and tacrolimus.
Przepiorka D, Ippoliti C, Khouri I, Anderlini P, Mehra R, Giralt S, Gajewski J, Fritsche H, Deisseroth AB, Cleary K, Champlin R, van Besien K, Andersson B, Korbling M. Przepiorka D, et al. Among authors: van besien k. Transplantation. 1996 Dec 27;62(12):1806-10. doi: 10.1097/00007890-199612270-00022. Transplantation. 1996. PMID: 8990368
Allogeneic blood stem cell transplantation in advanced hematologic cancers.
Przepiorka D, Anderlini P, Ippoliti C, Khouri I, Fietz T, Thall P, Mehra R, Giralt S, Gajewski J, Deisseroth AB, Cleary K, Champlin R, van Besien K, Andersson B, Körbling M. Przepiorka D, et al. Among authors: van besien k. Bone Marrow Transplant. 1997 Mar;19(5):455-60. doi: 10.1038/sj.bmt.1700692. Bone Marrow Transplant. 1997. PMID: 9052911
Allogeneic blood or marrow transplantation for chronic lymphocytic leukaemia: timing of transplantation and potential effect of fludarabine on acute graft-versus-host disease.
Khouri IF, Przepiorka D, van Besien K, O'Brien S, Palmer JL, Lerner S, Mehra RC, Vriesendorp HM, Andersson BS, Giralt S, Körbling M, Keating MJ, Champlin RE. Khouri IF, et al. Among authors: van besien k. Br J Haematol. 1997 May;97(2):466-73. doi: 10.1046/j.1365-2141.1997.272673.x. Br J Haematol. 1997. PMID: 9163617 Free article.
Engraftment of allogeneic hematopoietic progenitor cells with purine analog-containing chemotherapy: harnessing graft-versus-leukemia without myeloablative therapy.
Giralt S, Estey E, Albitar M, van Besien K, Rondón G, Anderlini P, O'Brien S, Khouri I, Gajewski J, Mehra R, Claxton D, Andersson B, Beran M, Przepiorka D, Koller C, Kornblau S, Kørbling M, Keating M, Kantarjian H, Champlin R. Giralt S, et al. Among authors: van besien k. Blood. 1997 Jun 15;89(12):4531-6. Blood. 1997. PMID: 9192777 Free article. Clinical Trial.
The impact of T-cell depletion on the effects of HLA DR beta 1 and DQ beta allele matching in HLA serologically identical unrelated donor bone marrow transplantation.
Gajewski J, Gjertson D, Cecka M, Tonai R, Przepiorka D, Hunt L, Giralt S, Chan KW, Feig S, Territo M, Andersson B, van Besien K, Khouri I, Fischer H, Babbitt L, Ippolitti C, Schiller G, Lill M, Warkentin D, Neumann J, Petz L, Terasaki P, Champlin R. Gajewski J, et al. Among authors: van besien k. Biol Blood Marrow Transplant. 1997 Jun;3(2):76-82. Biol Blood Marrow Transplant. 1997. PMID: 9267667 Clinical Trial.
Allogeneic transplantation for recurrent or refractory non-Hodgkin's lymphoma with poor prognostic features after conditioning with thiotepa, busulfan, and cyclophosphamide: experience in 44 consecutive patients.
van Besien K, Thall P, Korbling M, Pugh WC, Khouri I, Mehra R, Giralt S, Anderlini P, Amin K, Mirza N, Seong D, Gajewski J, Hester J, Andersson B, Cabanillas F, Champlin R, Przepiorka D. van Besien K, et al. Biol Blood Marrow Transplant. 1997 Aug;3(3):150-6. Biol Blood Marrow Transplant. 1997. PMID: 9310192 Clinical Trial.
Carmustine, etoposide, cytarabine and melphalan as a preparative regimen for allogeneic transplantation for high-risk malignant lymphoma.
Przepiorka D, van Besien K, Khouri I, Hagemeister F, Samuels B, Folloder J, Ueno NT, Molldrem J, Mehra R, Körbling M, Giralt S, Gajewski J, Donato M, Cleary K, Claxton D, Braunschweig I, Andersson B, Anderlini P, Champlin R. Przepiorka D, et al. Among authors: van besien k. Ann Oncol. 1999 May;10(5):527-32. doi: 10.1093/oxfordjournals.annonc.a010369. Ann Oncol. 1999. PMID: 10416001 Free article.
332 results